Dolinnov
PrivateLast Round
Seed
Oct 1, 2024
Total Funding Raised
$1.73M
Company Overview
Dolinnov is a biotechnology company developing precision RNA therapeutics for chronic pain, specifically targeting the FXYD2 protein to provide non-opioid pain relief.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dolinnov Comparables
Compare Dolinnov with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quiver Bioscience | 78% | |
| Latigo Biotherapeutics | 71% | |
| Exicure, Inc. | 69% |
Dolinnov Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 1, 2024 |
Dolinnov Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 100% QoQ from 4 to 8 employees.
- Mar 1, 2026
Monthly visitors increased 470% MoM.
Dolinnov Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dolinnov's valuation, stock price, and market status.
Is Dolinnov a public or private company?
Dolinnov is a private company.
What is the current stock price of Dolinnov?
Dolinnov is a private company with no public stock price. No recent secondary market data is available.
How much is Dolinnov worth (valuation)?
Valuation information for Dolinnov is not publicly available.
Can I buy Dolinnov stock?
Dolinnov shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Dolinnov's last funding round?
Dolinnov's most recent funding round was Seed on October 1, 2024.
Who are the main investors in Dolinnov?
Key investors in Dolinnov include Bpifrance.
Will Dolinnov IPO soon?
No public IPO plans have been announced for Dolinnov.
How can I track Dolinnov secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dolinnov's secondary market activity and sign up for updates.